EGFR–Co-Mutated Advanced NSCLC and Response to EGFR Tyrosine Kinase Inhibitors

Authors

Keywords

EGFR, Co-mutation, Double mutation, Multiple mutation, Tyrosine kinase inhibitors

Journal

Volume 12, Issue 3, Pages 585-590

Publisher

Elsevier BV

Online

2016-09-16

DOI

10.1016/j.jtho.2016.09.001

Contact the author

Explore over 38,000 international journals covering a vast array of academic fields.

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now